AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2018
Mar 21, 2018
34519_dirs_2018-03-21_6195a384-ac70-4233-aa27-a843f733679f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2018-03-19
Reporting Person: ROTHSCHILD JONATHAN E (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-19 | Incentive Stock Options (Right to buy) | $7.0800 | A | 15000.0000 | Acquired | 2028-03-19 | Common Stock (15000.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23